Recuro Health Supports SIIA Annual Meeting: Provides Voluntary COVID-19 Antigen Rapid Testing for Attendees, CEO Michael Gorton Panel Presenter

September 21, 2021

DALLAS—(BUSINESS WIRE)—Recuro Health(Recuro), an integrated digital health solutions company that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes approach, today announces that it will provide COVID-19 antigen rapid tests on a voluntary basis to all attendees during SIIA’s 41st Annual National Educational Conference, October 3-5, 2021, Austin, TX. Michael Gorton,…

Read More

Recuro Health Acquires MyLifeIQ, Brings Epigenetics & Precision Medicine to its Rapidly Expanding Suite of Digital Health Solutions

September 8, 2021

DALLAS—(BUSINESS WIRE)—Recuro Health(Recuro), an integrated digital health solution that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes approach, today announces the acquisition of MyLifeIQ, an epigenetics platform that transitions healthcare to precision medicine. By simplifying and customizing health information to unlock an individual’s full potential and improve quality of…

Read More

Recuro Health Publishes White Paper Documenting Value of an End-to-End Solution for At-Home COVID-19 Lab Testing to Ensure Workplace and School Safety

August 30, 2021

DALLAS—(BUSINESS WIRE)—Recuro Health (Recuro), an integrated digital health solution that evolves healthcare from a reactive, disease-focused model to a personalized, proactive system, today announced the release of its first white paper, “Rebound from COVID-19: At-Home COVID-19 Lab Tests Via an Integrated Care Solution Platform and Patient Portal,” authored by Jay Sanders, MD, founder of the American…

Read More

Recuro Health Announces Its $15 Million Series A Round Led by ARCH Venture Partners: Funds Additional Acquisitions Expanding Digital Health Solutions Capabilities, Increased Marketing, Company Growth

August 25, 2021

DALLAS—(BUSINESS WIRE)—Recuro Health (Recuro), an integrated digital health solutions company that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes approach, today announces a $15 million Series A financing led by ARCH Venture Partners, with follow-on support from existing Seed Round-investors OLSF Ventures, Cortado Ventures, 1843 Capital and Sage Venture Partners. Proceeds…

Read More

Vaccinate or Get Tested: Federal & State Governments, CDC, Corporations Issue New Directives as Delta Variant Fuels Demand for Recuro COVID At-Home or Onsite Testing Platform

August 2, 2021

DALLAS—(BUSINESS WIRE)—Recuro Health (Recuro), an integrated digital health solution that evolves healthcare from a reactive, disease-focused model to a personalized, proactive system, reports sharp, increased employer demand for at-home or on site COVID testing to ensure a safe return-to-work and participation at crucial meetings, events and conventions. Amid the surge of the Delta variant, recurrence of…

Read More

Recuro Health Integrated Solutions Platform Supports Employers, Payers, Government Manage Population Health Post COVID: Featured at HHS RADx Summit

July 15, 2021

DALLAS — (BUSINESS WIRE) — Recuro Health (Recuro), an integrated digital health solution that evolves healthcare from a reactive, disease-focused model to a personalized, proactive system, will be featured at the Association of Chamber of Commerce Executives (ACCE) Innovation Summit July 19-21 sponsored by RADx, an initiative of the U.S. Department of Health and Human Services (HHS). Recuro’s integrated, interoperable…

Read More

Recuro Health Further Expands Digital Solution Platform: Acquires My Legacy Decision Support App, Integrates Genetic Profiles to Enhance Disease Management & Care Coordination

June 22, 2021

DALLAS — (BUSINESS WIRE) — Recuro Health (Recuro), an integrated digital health solution that evolves healthcare from a reactive, disease-focused model to a personalized, proactive system, announces the acquisition of MyLegacy, a risk stratification tool and clinical decision support application which uses proprietary algorithms based on practice guidelines developed by the Cleveland Clinic Genomic Medicine Institute.…

Read More

Recuro Health At-Home COVID-19 Rapid Testing Solution Featured at U.S. Census Bureau & Department of Health & Human Services COVID-19 TOPx Solutions Showcase

May 24, 2021

DALLAS — (BUSINESS WIRE) — Recuro Health At-Home Testing (otherwise known as UDoTest), an at-home diagnostic and health screening software platform designed to personalize the at-home testing experience, announces that its COVID-19 rapid test solution will be featured at the HHS TOPx Solution Showcase, Thursday, May 25, 2021, 12-3 p.m. ET. The virtual event is co-hosted…

Read More

Recuro Health Acquires SupDoc: Expands Digital Care Platform, Enhances Virtual Primary Care and Behavioral Health Solutions

May 20, 2021

DALLAS — (BUSINESS WIRE) — Recuro Health (Recuro), an integrated digital health solution that evolves healthcare from a reactive, disease-focused model to a personalized, proactive system, today announces the acquisition of SupDoc, an AI-enabled virtual health solution that offers a holistic and cost-effective model for care delivery. With this acquisition, SupDoc will enhance Recuro’s virtual health…

Read More

Recuro Health Acquires UDoTest: Integrates At-Home Lab into Digital Solutions Hub, Broadens Care Pathways for Employers, Payers and Patients, Offers COVID-19 Test Supporting Return-to-Work

May 6, 2021

DALLAS — (BUSINESS WIRE) — Recuro Health (Recuro), an integrated digital health solution that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health outcomes approach, today announces the acquisition of UDoTest, Inc., a global, award-winning at-home diagnostic and health screening software platform designed to personalize the at-home testing experience with…

Read More
SIIA 1

Recuro Proud to Support 2021 SIIA Annual Meeting: Recuro CEO Michael Gorton Participates on Visionary Panel Exploring Future of Digital Health   

SIIA’s 41st Annual National Educational Conference, October 3-5, 2021, Austin, TX was a great opportunity for Recuro Health to support SIIA and for Recuro’s rollout to employers of its multi-prong digital health solution, including COVID-19 antigen testing and vaccine tracking status capabilities.  On a voluntary basis...